Published: Apr-2021 | Format: PDF | Market Research Store | Number of pages: 147 | Code: MRS - 828578
According to the report published by Market Research Store, global demand for the acute otitis media treatment market was estimated at approximately USD 2,100 Million in 2019 and is anticipated to generate revenue of around USD 3,000 Million by end of 2026, growing at a CAGR of around 5% between 2020 and 2026.
Global Acute Otitis Media Treatment Market: Overview
Acute otitis media (AOM) is a chronic ear infection that often affects kids. The illness causes middle-ear inflammation, resulting in a middle-ear injection. After upper respiratory tract infection, it is the second most prevalent condition in infants with fever, irritability, otalgia, and ear discharge are all signs of the condition. Acute otitis media (AOM) affects about 80% of children between the ages of one and five. Acute otitis media has a global prevalence rate of 10.85 percent globally. Per year, 709 million cases of acute otitis media are registered around the world, with 51 percent of these cases occurring in children under the age of five. Children aged 6 to 18 months have a high chance of contracting the disease. If left unchecked, the condition can lead to permanent hearing loss. A person's hearing loss/impairment, intracranial infection, and facial paralysis may all occur as a result of prolonged acute otitis media episodes. The causative agents of this infection are bacteria and viruses. The main pathogen that causes this infection is named streptococcus pneumoniae. Acute otitis media is caused by bacteria in approximately 35 percent to 55 percent of cases, and viruses in approximately 20 percent to 30 percent of cases. If the patient does not respond to any of the above-mentioned drugs, the practitioner will administer steroids for the treatment of acute otitis media. If drug therapy fails to cure acute otitis media, a physician may advise the patient to seek surgical care for acute otitis media. Tympanocentesis, myringotomy, and tympanostomy are the three surgical methods for treating acute otitis media.
Global Acute Otitis Media Treatment Market: Growth Factors
The global acute otitis media care treatment market is being driven by an increase in the number of cases of acute otitis media across the globe. Other causes that contribute to an uptick in the number of acute otitis media cases include an increase in maternal age, children of aboriginal descent, and the number of women who smoke during pregnancy. The launch of innovative drugs for the treatment of acute otitis media by leading pharmaceutical firms would fuel the market's expansion in the forecasted period. The treatment is also expected to rise owing to the availability of generic medications at a cheaper cost than marketed drugs for acute otitis media treatment. However, the demand for the development of acute otitis media treatment could be hampered by stringent guidelines set out by different government agencies for the approval of drugs for the treatment of acute otitis media in children over the projected timeframe. In addition, in emerging economies, a lack of public knowledge about ear infections may slow the growth of the acute otitis media treatment market. Antibiotic resistance mutations are emerging as a result of the widespread use of antibiotics to combat acute otitis media, limiting the use of such medications in the treatment of the disease which further restrains the market growth. Nevertheless, During the forecast era, an increasing amount of research and development activities by numerous main actors, as well as their underlying clinical trial trials for the treatment of acute otitis media, are expected to show lucrative growth prospects. For example, Novus Therapeutics, Inc., a specialty pharmaceutical company focused on the development of drugs for patients with ENT conditions, is currently conducting phase I clinical trials for OP-O2.
Global Acute Otitis Media Treatment Market: Segmentation
Based on drug type, the market is bifurcated into categories such as antibiotics, a nonsteroidal anti-inflammatory drug, analgesic, and anesthetic. Further based on the formulation market is further bifurcated into categories such as topical and oral. On the basis of end user, the market is further split into hospitals, retail pharmacies, and online pharmacies.
Global Acute Otitis Media Treatment Market: Regional Analysis
Because of the high availability of experimental medications for acute otitis media treatment in the United States and Canada, North America is projected to lead the market share in the coming years. Following North America, Europe dominates the market owing to a growing patient pool suffering from an ear infection in the European Union countries. The availability of generic acute otitis media treatment drugs in India and China is a major factor driving the Asia-Pacific Acute Otitis Media Treatment industry. Because of the scarcity of medical facilities in this country, MEA and Latin America are less appealing segments for the Acute Otitis Media Treatment industry. The leading countries in the Acute Otitis Media Treatment industry are China, India, Brazil, and Russia.
Global Acute Otitis Media Treatment Market: Competitive Players
The major players dominating the global acute otitis media treatment market in terms of revenue and development are Eli Lilly and Company, Janssen Pharmaceuticals, Takeda Pharmaceuticals, Johnson and Johnson, Pfizer, Inc., Bristol Myers, Squibb Company, Teva Pharmaceuticals, Astellas Pharma, Inc., Abbott, Novartis AG, AstraZeneca Plc, Sanofi, GlaxoSmithKline plc, Bayer AG, and Others. These major companies have used a variety of tactics to gain a reputable foothold in the global industry, including negotiating deals, bonds, contracts, alliances, joint ventures, innovative drug type releases, collaborations, and mergers and acquisitions. Aurobindo Pharma Ltd. obtained FDA clearance in 2015 to sell its generic antibiotic Cefixime in the United States. Cefixime is a cephalosporin of the third generation that is used to treat acute otitis media.
Acute Otitis Media Treatment Market: Regional Segment Analysis
Acute Otitis Media Treatment
Acute Otitis Media Treatment